Subscription status
- Qualified institutional buyers (QIB)172.03x
- Non-institutional investors (NII)73.63x
- NII: bids above ₹10 lakh (big NII)82.92x
- NII: bids of ₹2–10 lakh (small NII)55.07x
- Retail investors12.96x
- Employees15.41x
- Total71.26x
Shares offered and bid for, by category
| Category | Shares offered | Shares bid for |
|---|---|---|
| Qualified institutional buyers (QIB) | 37,39,872 | 64,33,59,195 |
| Foreign institutions (FII) | – | 12,59,47,230 |
| Banks, financial institutions and insurers | – | 36,76,69,110 |
| Mutual funds | – | 3,49,90,815 |
| Other institutions | – | 11,47,52,040 |
| Non-institutional investors (NII) | 28,04,904 | 20,65,35,120 |
| NII: bids above ₹10 lakh (big NII) | 18,69,936 | 15,50,46,495 |
| Corporates | – | 12,53,805 |
| Individuals(Other than RIIs) | – | 14,63,23,875 |
| Others | – | 74,68,815 |
| NII: bids of ₹2–10 lakh (small NII) | 9,34,968 | 5,14,88,625 |
| Corporates | – | 1,44,720 |
| Individuals(Other than RIIs) | – | 4,95,61,725 |
| Others | – | 17,82,180 |
| Retail investors | 65,44,776 | 8,48,10,330 |
| Cut Off | – | 7,22,08,140 |
| Price bids | – | 1,26,02,190 |
| Employees | 35,377 | 5,45,055 |
| Cut Off | – | 4,55,625 |
| Price Bids | – | 89,430 |
| Total | 1,31,24,929 | 93,52,49,700 |
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (minimum) | 1 | 15 | ₹14,820 |
| Retail (maximum) | 13 | 195 | ₹1,92,660 |
| Small NII / sHNI (minimum) | 14 | 210 | ₹2,07,480 |
| Small NII / sHNI (maximum) | 67 | 1,005 | ₹9,92,940 |
| Big NII / bHNI (minimum) | 68 | 1,020 | ₹10,07,760 |
IPO details
| Company | Symbiotec Pharmalab Limited |
|---|---|
| Board | Mainboard (NSE and BSE) |
| Issue period | Mon, 24 Aug 2026 to Thu, 27 Aug 2026 |
| Price band | ₹938 – ₹988 |
| Face value | ₹2 per share |
| Lot size | 15 shares |
| Cut-off time for UPI Mandate Confirmation | 27-Aug-2026 (upto 5:00 PM) The new cut-off time for UPI mandate acceptance is 05:00 PM on last day of IPO bidding. |
| Issue Size | Initial Public Offer of Fresh Issue of Aggregating Up to Rs. |
| Issue Type | Book Building |
| Discount | Rs. 90 per equity share to Eligible Employees |
| Tick Size | Re. 1 |
| Maximum Subscription Amount for Retail Investor | Rs. 2,00,000 |
| Maximum Subscription Amount for Eligible Employee | Rs. 5,00,000 |
| Maximum Bid Quantity for QIB Investors | 1,30,89,540 Equity Shares in multiple of 15 Equity Shares |
| Maximum Bid Quantity for NIB Investors | 93,49,680 Equity Shares in multiple of 15 Equity Shares |
| IPO Market Timings | 10.00 a.m. to 5.00 p.m. |
| Sponsor Bank | Axis Bank Limited and Kotak Mahindra Bank Limited |
| Contact person name number and Email id | Shanti Gopalkrishnan, +91 810 811 4949 , symbiotecpharmalab.ipo@in.mpms.mufg.com |
| Registrar | MUFG Intime India Private Limited |
| Lead managers | JM Financial Limited, Avendus Capital Private Limited, Motilal Oswal Investment Advisors Limited and Nomura Financial Advisory and Securities (India) Private Limited |
Offer documents
Frequently asked questions
When does the Symbiotec Pharmalab IPO open and close?
It opens on Mon, 24 Aug 2026 and closes on Thu, 27 Aug 2026.
What is the price band of the Symbiotec Pharmalab IPO?
₹938 – ₹988 per share, with a face value of ₹2.
What is the lot size and minimum investment?
One lot is 15 shares. The minimum application is one lot, which costs ₹14,820 at the top of the price band.
When is the allotment and listing date?
Allotment was on Fri, 28 Aug 2026 and the shares listed on Tue, 1 Sep 2026.
What was the Symbiotec Pharmalab IPO listing gain?
It listed at ₹988 on Tue, 1 Sep 2026, a gain of 0.0% on the issue price of ₹988.
How do I check the Symbiotec Pharmalab IPO allotment status?
On the registrar's website (MUFG Intime India Private Limited) or the NSE and BSE allotment pages, using your PAN or application number, from the allotment date.
For information only. Not investment advice. SmartFigure is not registered with SEBI as an investment adviser or research analyst. GMP is an unofficial, unregulated grey-market figure, averaged from public websites; it is not a prediction of the listing price. Rely on the offer documents.